Neoadjuvant systemic therapy — typically chemotherapy, targeted therapy, or hormonal therapy given before surgery — is often used to shrink tumors in breast cancer. For many women, this treatment transforms what would have required a mastectomy into an opportunity for breast conservation.
At Apollo Athenaa, breast-conserving surgery following neoadjuvant therapy is performed with precision. Our approach not only aims to remove all residual disease, but also preserves breast shape and appearance wherever safely possible. Every plan is guided by pre-treatment imaging (including MRI breast with contrast and image guided clip placement into the tumor), tumor biology, and careful response assessment.